ClinicalTrials.govpublic full text
Sodium/Glucose Cotransporter-2 Inhibitors (SGLT2i) Therapy in Duchenne Cardiomyopathy
duchenne muscular dystrophy (dmd), cardiomyopathy, heart failure, muscular dystrophy, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 885034
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.